Drug Shortage Report for MYLAN-CANDESARTAN
Report ID | 5042 |
Drug Identification Number | 02379139 |
Brand name | MYLAN-CANDESARTAN |
Common or Proper name | CANDESARTAN |
Company Name | MYLAN PHARMACEUTICALS ULC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | CANDESARTAN CILEXETIL |
Strength(s) | 8MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 100 |
ATC code | C09CA |
ATC description | ANGIOTENSIN II ANTAGONISTS, PLAIN |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2017-05-15 |
Estimated end date | 2018-08-10 |
Actual end date | 2018-08-10 |
Shortage status | Resolved |
Updated date | 2018-08-11 |
Company comments | Discontinued in record 53616 |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.